Figure 3.
Scanning electron micrographs of (A) uncoated polyglycolic acid microneedle, (B) matrix-assisted pulsed laser evaporationcoated microneedle from deposition with the AmfB(260) target (amphotericin B 1040 mg/mL + 1% polyvinylpyrrolidone), and (C) matrix-assisted pulsed laser evaporation-coated microneedle from deposition with the AmfB(520) target (amphotericin B 2080 mg/mL + 1% polyvinylpyrrolidone).